Human liver quality is a dominant factor in the outcome of in vitro studies

Cell Biology and Toxicology

Volumn 17, Issue 3, 2001, Pages 179-189

  Fisher, R L ^a   Gandolfi, A J ^b   Brendel, K ^c  

^a Vitron Inc   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Cellular viability; Human liver; Precision cut slices

Indexed keywords

BENZENE DERIVATIVE; XENOBIOTIC AGENT;

ARTICLE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LIVER CELL; LIVER METABOLISM; OUTCOMES RESEARCH; PRIORITY JOURNAL; TISSUE SLICE; XENOBIOTIC METABOLISM;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; CHLOROBENZENES; CRYOPRESERVATION; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; INSECTICIDES; L-LACTATE DEHYDROGENASE; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POTASSIUM; PROTEIN BIOSYNTHESIS; TISSUE DONORS;

EID: 0034792956     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011944531257     Document Type: Article

References (27)

1. Effective cryopreservation and long-term storage of primary human hepatocytes with recovery of viability, differentiation, and replicative potential
2. Update on preservation of liver grafts
3. Early graft function in liver transplantation: Comparison of two techniques of graft procurement
4. Cryopreservation of rat and human liver slices by rapid freezing
5. Metabolism of dichlorobenzenes in organ cultured liver slices
6. In vitro hepatotoxicity of three dichlorobenzene isomers in human liver slices
7. Valproic acid hepatotoxicity in human liver slices
8. Cold- and cryopreservation of human liver and kidney slices
9. Toxicity of valproic acid and its metabolites in adult and neonatal rats and human liver slices
10. Dynamic organ culture is superior to multiwell plate culture for maintaining precision cut tissue slices: Optimization of tissue slice culture. Part 1
11. Cold- and cryo-preservation of dog liver and kidney slices
12. Comparison of human hepatocytes isolated from livers accepted or discarded for orthotopic transplantation
13. Prediction of hepatic clearance from microsomes, hepatocytes and liver slices
14. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury
15. 3,3-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices
16. Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices
17. Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: Evaluation of model drugs terfenadine and rifampin
18. In vitro human tissue models in risk assessment: Report of a consensus-building workshop
19. Carolina Rinse Solution decreases liver injury during clinical liver transplantation
20. U.S. system for organ procurement and transplantation
21. Cultured hepatocytes as investigational models for hepatic toxicity: Practical application in drug discovery and development
22. Use of human organ slices to evaluate the biotransformation and drug-induced side effects of pharmaceuticals
23. Changes in human liver and kidney slice function related to potential side effects in the presence of biotransformation of four cyclosporin derivatives - CSA, IMM, OG, and PSC
24. The role of the United Network for Organ Sharing and designated organ procurement organizations in organ retrieval for transplantation